Cathay Health is dedicated to investing in companies at the convergence of life sciences, healthcare and technology with positive impact on human health.
With a reach spanning key bio and tech hubs around the globe, we help companies scale across borders and access new markets, partners and patients.
Our Strategy
We back venture- and growth-stage companies with emerging technologies that catalyze groundbreaking advances in healthcare.
We fund future leaders in tech-enabled medicine with differentiated approaches and strong intellectual property to personalize care, improve access and lower cost.
We invest in Series A to C rounds with the ability to lead or co-invest, and help companies scale across borders.
Our Focus Areas
- Life Science Tools
- Diagnostics
- Clinical Trial Innovation
- New Care Models
- Novel Devices & Materials
- Enabling Technologies For Advanced Therapies
Why Cathay Health
- A global platform catalyzing cross-industry collaboration: Cathay Health is affiliated to Cathay Capital – a global investment platform connecting partners and catalyzing collaborations across Europe, North America and Asia to solve the world’s most pressing challenges.
- Scaling companies to transform health across borders: Our global network and operating expertise across regions allows us to grow impactful companies that serve patients worldwide.
- Deep expertise in both healthcare and technology: Our unique expertise allows us to identify investment opportunities with the largest impact on human health and care.
Investing & operating at the convergence
Our team not only invests – but brings operating experience – at the convergence of life sciences, healthcare and tech. Our expertise uniquely bridges these complementary fields to maximize the potential of our portfolio companies.